Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations

por Scolnik, Marina, Singh, Gurkirpal
Publicado 2011

Celecoxib in arthritis: relative risk management profile and implications for patients

por McKellar, Gayle, Singh, Gurkirpal
Publicado 2009

Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis

por Singh, Gurkirpal, Wu, Olivia, Langhorne, Peter, Madhok, Rajan
Publicado 2006

Concurrent Conditions in Patients with Chronic Constipation: A Population–Based Study

por Arora, Gaurav, Mannalithara, Ajitha, Mithal, Alka, Triadafilopoulos, George, Singh, Gurkirpal
Publicado 2012

Severe Thyroid Eye Disease in the US: A National Perspective

por Singh, Gurkirpal, Sehgal, Maanek, Mithal, Alka, Alabiad, Chris, Kossler, Andrea
Publicado 2021

GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded end point (PROBE) trial

por Cryer, Byron, Li, Chunming, Simon, Lee S, Singh, Gurkirpal, Stillman, Martin J, Berger, Manuela
Publicado 2012

GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial

por Cryer, Byron, Li, Chunming, Simon, Lee S, Singh, Gurkirpal, Stillman, Martin J, Berger, Manuela F
Publicado 2013

Affordable Care Act and healthcare delivery: A comparison of California and Florida hospitals and emergency departments

por Barakat, Monique T., Mithal, Aditi, Huang, Robert J., Mithal, Alka, Sehgal, Amrita, Banerjee, Subhas, Singh, Gurkirpal
Publicado 2017

Interleukin 6 Inhibition and Coronary Artery Disease in a High‐Risk Population: A Prospective Community‐Based Clinical Study

por Bacchiega, Bruno Cesar, Bacchiega, Ana Beatriz, Usnayo, Magali Justina Gomez, Bedirian, Ricardo, Singh, Gurkirpal, Pinheiro, Geraldo da Rocha Castelar
Publicado 2017